We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBY
2901
DELISTED
Libbey, Inc.
LBY
$7K ﹤0.01%
+355
New +$6.41K
HOS
2902
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$7K ﹤0.01%
948
+705
+290% +$4.13K
XCRA
2903
DELISTED
Xcerra Corporation
XCRA
$7K ﹤0.01%
+929
New +$5.99K
VR
2904
DELISTED
Validus Hold Ltd
VR
$7K ﹤0.01%
119
-1,362
-92% -$72K
DHXM
2905
DELISTED
DHX Media Ltd. Common Voting and Variable Voting Shares
DHXM
$7K ﹤0.01%
1,000
-2,938
-75% -$15K
STB
2906
DELISTED
Student Transportation Inc
STB
$7K ﹤0.01%
1,175
+75
+7% +$433
NVIV
2907
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
0
STRP
2908
DELISTED
Straight Path Communications Inc.
STRP
$7K ﹤0.01%
+200
New +$5.52K
SCMP
2909
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$7K ﹤0.01%
574
+473
+468% +$6.6K
UTEK
2910
DELISTED
Ultratech Inc.
UTEK
$7K ﹤0.01%
+307
New +$7K
IQNT
2911
DELISTED
Inteliquent, Inc.
IQNT
$7K ﹤0.01%
+300
New +$6.17K
BEBE
2912
DELISTED
Bebe Stores Inc
BEBE
$7K ﹤0.01%
1,310
-1,419
-52% -$8.21K
ZGNX
2913
DELISTED
Zogenix, Inc.
ZGNX
$7K ﹤0.01%
560
+1
+0.2% +$11
PFSW
2914
DELISTED
PFSweb, Inc.
PFSW
$7K ﹤0.01%
794
+775
+4,079% +$6.37K
AAWW
2915
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$7K ﹤0.01%
+130
New +$6.14K
ARLZ
2916
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$7K ﹤0.01%
1,201
-1,298
-52% -$6.16K
MRVC
2917
DELISTED
MRV Communications Inc
MRVC
$7K ﹤0.01%
814
-1,430
-64% -$13.4K
CFCB
2918
DELISTED
Centrue Financial Corporation
CFCB
$7K ﹤0.01%
309
-491
-61% -$9.79K
STL
2919
DELISTED
Sterling Bancorp
STL
$7K ﹤0.01%
+300
New +$6.21K
FDC
2920
DELISTED
First Data Corporation
FDC
$7K ﹤0.01%
+482
New +$6.85K
BHAC
2921
DELISTED
Barington/Hilco Acquisition Corp.
BHAC
$7K ﹤0.01%
700
-276
-28% -$2.81K
ACNB icon
2922
ACNB Corp
ACNB
$655M
$6K ﹤0.01%
205
+144
+236% +$4.2K
OSG
2923
Octave Specialty Group
OSG
$222M
$6K ﹤0.01%
258
-1,426
-85% -$31.2K
BLDP
2924
Ballard Power Systems
BLDP
$790M
$6K ﹤0.01%
2,500
-9,688
-79% -$19.3K
BSM icon
2925
Black Stone Minerals
BSM
$3B
$6K ﹤0.01%
300
-430
-59% -$7.88K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.